Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

KalVista Pharmaceuticals (KALV) Return on Assets (2017 - 2025)

KalVista Pharmaceuticals' Return on Assets history spans 10 years, with the latest figure at 0.0% for Q2 2025.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q2 2025 year-over-year; TTM through Apr 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Assets hit 0.0% in Q2 2025 for KalVista Pharmaceuticals, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Assets for KALV hit a ceiling of 0.0% in Q2 2023 and a floor of 0.01% in Q1 2024.
  • Historically, Return on Assets has averaged 0.0% across 4 years, with a median of 0.0% in 2024.
  • The widest YoY moves for Return on Assets: up 0bps in 2021, down 0bps in 2021.
  • Tracing KALV's Return on Assets over 4 years: stood at 0.0% in 2021, then plummeted by -64bps to 0.0% in 2023, then skyrocketed by 36bps to 0.0% in 2024, then skyrocketed by 32bps to 0.0% in 2025.
  • Business Quant data shows Return on Assets for KALV at 0.0% in Q2 2025, 0.0% in Q4 2024, and 0.0% in Q4 2024.